1. Home
  2. PCRX vs WEAV Comparison

PCRX vs WEAV Comparison

Compare PCRX & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • WEAV
  • Stock Information
  • Founded
  • PCRX 2006
  • WEAV 2011
  • Country
  • PCRX United States
  • WEAV United States
  • Employees
  • PCRX N/A
  • WEAV N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • WEAV EDP Services
  • Sector
  • PCRX Health Care
  • WEAV Technology
  • Exchange
  • PCRX Nasdaq
  • WEAV Nasdaq
  • Market Cap
  • PCRX 1.2B
  • WEAV 1.3B
  • IPO Year
  • PCRX 2011
  • WEAV 2021
  • Fundamental
  • Price
  • PCRX $25.16
  • WEAV $14.25
  • Analyst Decision
  • PCRX Buy
  • WEAV Strong Buy
  • Analyst Count
  • PCRX 9
  • WEAV 5
  • Target Price
  • PCRX $26.22
  • WEAV $16.50
  • AVG Volume (30 Days)
  • PCRX 805.4K
  • WEAV 1.2M
  • Earning Date
  • PCRX 02-27-2025
  • WEAV 02-20-2025
  • Dividend Yield
  • PCRX N/A
  • WEAV N/A
  • EPS Growth
  • PCRX N/A
  • WEAV N/A
  • EPS
  • PCRX N/A
  • WEAV N/A
  • Revenue
  • PCRX $694,957,000.00
  • WEAV $204,314,000.00
  • Revenue This Year
  • PCRX $5.55
  • WEAV N/A
  • Revenue Next Year
  • PCRX $5.64
  • WEAV N/A
  • P/E Ratio
  • PCRX N/A
  • WEAV N/A
  • Revenue Growth
  • PCRX 4.40
  • WEAV 19.85
  • 52 Week Low
  • PCRX $11.16
  • WEAV $8.10
  • 52 Week High
  • PCRX $31.67
  • WEAV $17.63
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 52.48
  • WEAV 25.41
  • Support Level
  • PCRX $25.41
  • WEAV $16.63
  • Resistance Level
  • PCRX $26.89
  • WEAV $17.63
  • Average True Range (ATR)
  • PCRX 1.18
  • WEAV 0.59
  • MACD
  • PCRX -0.36
  • WEAV -0.23
  • Stochastic Oscillator
  • PCRX 4.35
  • WEAV 13.78

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

Share on Social Networks: